Yifan Pharmaceutical Co (SZSE:002019) Cash Flow for Dividends : ¥-197 Mil (TTM As of Sep. 2024)

View and export this data going back to 2004. Start your Free Trial

What is Yifan Pharmaceutical Co Cash Flow for Dividends?

Yifan Pharmaceutical Co's cash flow for dividends for the three months ended in Sep. 2024 was ¥-147 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Sep. 2024 was ¥-197 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

Yifan Pharmaceutical Co's quarterly payment of dividends increased from Mar. 2024 (¥-16 Mil) to Jun. 2024 (¥-17 Mil) and increased from Jun. 2024 (¥-17 Mil) to Sep. 2024 (¥-147 Mil).

Yifan Pharmaceutical Co's annual payment of dividends declined from Dec. 2021 (¥-138 Mil) to Dec. 2022 (¥-86 Mil) and declined from Dec. 2022 (¥-86 Mil) to Dec. 2023 (¥-72 Mil).

Yifan Pharmaceutical Co Cash Flow for Dividends Historical Data

The historical data trend for Yifan Pharmaceutical Co's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Yifan Pharmaceutical Co Cash Flow for Dividends Chart

Yifan Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash Flow for Dividends

Get a 7-Day Free Trial

-192.34

-201.98

-138.39

-86.39

-72.47

Yifan Pharmaceutical Co Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Cash Flow for Dividends	Get a 7-Day Free Trial															-9.25	-16.89	-15.80	-16.86	-147.38

Yifan Pharmaceutical Co Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-197 Mil.

Yifan Pharmaceutical Co Cash Flow for Dividends Related Terms

Thank you for viewing the detailed overview of Yifan Pharmaceutical Co's Cash Flow for Dividends provided by GuruFocus.com. Please click on the following links to see related term pages.

Yifan Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Yifan Pharmaceutical Co Ltd (SZSE:002019) » Definitions » Cash Flow for Dividends

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 50 Qinshan, Jincheng, Lin'an Economic Development Zone, Hangzhou, Zhejiang, CHN, 311300

Website

https://en.yifanyy.com

Yifan Pharmaceutical Co Ltd is a China-based company engaged in R&D and production company focusing on the pharmaceutical and health sectors. Its vision is to develop drugs with definite clinical values, to help disease-afflicted patients regain health. The group focuses on four business areas such as biologics, small molecules, synthetic biologics, and special traditional Chinese medicines (TCMs). The products of the company are Ryzneuta, Plerixafor Injection, Vincristine Sulfate, Skin Allergy Reli, and Others.

Executives

Ye Yi Qun	Director
Zhang Da Wei	Executives
Geng Yu Hong	Executives
Feng De Qi	Directors, Directors, and Executives
Zhou Ben Yu	Director
Lin Xing	Directors, executives
Yu Hai Xia	Executives
Cheng Xian Feng	Directors, executives
Xu Guo Han	Supervisors
Cao Shi Mei	Director
Lin Guan Yu	Director
Zhang Lian Chun	Executives
Guo Xin Fu	Director
Zheng Shi Ming	Supervisors
Yin Hang Hua	Executives

Yifan Pharmaceutical Co Headlines

No Headlines